{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:53:45Z","timestamp":1791075225037,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jconrel.2011.10.013","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T11:37:09Z","timestamp":1319456229000},"page":"63-71","source":"Crossref","is-referenced-by-count":38,"title":["In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain"],"prefix":"10.1016","volume":"158","author":[{"given":"S. Rahima","family":"Benhabbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christopher","family":"Luft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anekant","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell J.","family":"Mumper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2011.10.013_bb0005","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.2174\/092986709789177984","article-title":"Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies","volume":"16","author":"Gialeli","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature01440","article-title":"Segregation of receptor and ligand regulates activation of epithelial growth factor receptor","volume":"422","author":"Vermeer","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0015","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","article-title":"Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer","volume":"21","author":"Mendelsohn","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0020","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0025","first-page":"4726","article-title":"Expression of epidermal growth-factor receptor in human cultured-cells and tissues \u2014 relationship to cell lineage and stage of differentiation","volume":"46","author":"Real","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/mp060105u","article-title":"Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells","volume":"4","author":"Yip","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0035","first-page":"1236","article-title":"Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy","volume":"59","author":"Yang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1677\/erc.1.00799","volume":"11","author":"Jones","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1634\/theoncologist.10-7-461","article-title":"FDA drug approval summary: Erlotinib (Tarceva (R)) tablets","volume":"10","author":"Cohen","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-suppl_3-10","article-title":"Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR\/ErbB-2 inhibitor lapatinib","volume":"9","author":"Burris","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0055","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.yexcr.2006.05.008","article-title":"Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting","volume":"312","author":"Jaramillo","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2009.07.005","article-title":"Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice","volume":"140","author":"Kim","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2004.08.007","article-title":"Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody","volume":"100","author":"Lukyanov","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0070","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jmb.2007.12.060","article-title":"Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule","volume":"376","author":"Friedman","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14712598.7.4.555","article-title":"Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy","volume":"7","author":"Tolmachev","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0080","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1111\/j.1742-4658.2008.06438.x","article-title":"Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold","volume":"275","author":"Nygren","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0085","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nbt0897-772","article-title":"Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain","volume":"15","author":"Nord","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00259-005-0012-3","article-title":"Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice","volume":"33","author":"Steffen","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/protein\/gzh053","article-title":"Selection and characterization of HER2\/neu-binding affibody ligands","volume":"17","author":"Wikman","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0100","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1158\/1078-0432.CCR-07-4076","article-title":"Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0105","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor Imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"Orlova","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/bc100432h","article-title":"Radio labeled affibody-albumin bioconjugates for HER2-positive cancer targeting","volume":"22","author":"Hoppmann","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2011.04.005","article-title":"Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)","volume":"153","author":"Smith","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2011.01.016","article-title":"Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant His-tagged antigens: preparation, structural study and immune response towards rHsp90","volume":"151","author":"Masek","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1021\/bc900309n","article-title":"Tris-nitrilotriacetic acids of subnanomolar affinity toward hexahistidine tagged molecules","volume":"20","author":"Szoka","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/bc0602228","article-title":"Facile synthesis of multivalent nitrilotriacetic acid (NTA) and NTA conjugates for analytical and drug delivery applications","volume":"17","author":"Szoka","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbamem.2005.09.003","volume":"1716","author":"van Broekhoven","year":"2005","journal-title":"Biomembranes"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11095-006-9154-7","article-title":"Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1081\/DDC-120002847","article-title":"Gadolinium-loaded nanoparticles engineered from microemulsion templates","volume":"28","author":"Oyewumi","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cyto.990100311","article-title":"New, simple flow-cytometry technique to discriminate between internalized and membrane-bound particles in phagocytosis","volume":"10","author":"Fattorossi","year":"1989","journal-title":"Cytometry"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0155","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/pola.10049","article-title":"2,2,6,6-tetramethyl-1-piperidinyl-oxyl\/[bis(acetoxy)-iodo]benzene-mediated oxidation: a versatile and convenient route to poly(ethylene glycol) aldehyde or carboxylic acid derivatives","volume":"39","author":"Masson","year":"2001","journal-title":"J. Polym. Sci. A1"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0160","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.1021\/ja074443f","article-title":"Dual-mode fluorophore-doped nickel nitrilotriacetic acid-modified silica nanoparticles combine histidine-tagged protein purification with site-specific fluorophore labeling","volume":"129","author":"Kim","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0165","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/0008-5472.CAN-08-2747","article-title":"Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting p-glycoprotein and depleting ATP","volume":"69","author":"Dong","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11095-006-9154-7","article-title":"Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0175","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/ma702074v","article-title":"Protein resistance of surfaces prepared by chemisorption of monothiolated poly(ethylene glycol) to gold and dendronization with aliphatic polyester dendrons: effect of hydrophilic dendrons","volume":"41","author":"Benhabbour","year":"2008","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0180","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1021\/ma8004586","article-title":"Protein resistance of PEG-functionalized dendronized surfaces: effect of PEG molecular weight and dendron generation","volume":"41","author":"Benhabbour","year":"2008","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2011.10.013_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpb.2008.11.012","article-title":"Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization","volume":"72","author":"Dong","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.10.013_bb0190","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/bc900448f","article-title":"Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached his(6)-protein","volume":"21","author":"Szoka","year":"2010","journal-title":"Bioconjug. Chem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911009850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911009850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T10:00:51Z","timestamp":1560852051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911009850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0168365911009850"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.10.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}